Professor Deborah Layton, FRCPharm, FISPE, PhD, is Chief Scientific Officer of PHARMO, part of Lumanity. In her role as CSO, she provides senior advisory input on post-authorization safety studies, risk management, and evidence governance. She is a pharmacoepidemiology and pharmacovigilance experty with over two decades' experience in medicines safety, real-world evidence, and regulatory decision support.
Deborah is an honorary professor at the University of Hertfordshire. She is widely published and has previously held numerous executive leadership roles, with responsibility for oversight of large, complex post-marketing safety programs using routine healthcare data.
Deborah holds a PhD from Utrecht University as well as Master of Science degrees in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London, and in Statistics with Applications in Medicine from the University of Southampton.